Encysive Pharmaceuticals (ENCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Encysive Pharmaceuticals (ENCY)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: idos	9/4/2007 1:05:47 PM
	of 205

Die hard ENCY: Encysive set for second Thelin trial Tuesday September 4, 11:36 am ET Encysive Pharmaceuticals Inc. has completed patient enrollment for its second phase of trials for its drug Thelin. The Houston biopharmaceutical company said the trial would yield results by the middle of next year. Encysive (NASDAQ: ENCY - News) is testing Thelin on about 150 patients suffering from diastolic heart failure, a type of congestive heart failure, at about 40 study centers. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next